Why the Simulation Condition Matters
A pharmacokinetic model can generate a concentration profile after one dose or under a repeated regimen at steady state. These are different simulation conditions, and they answer different questions. A single-dose profile describes the response to one administration in a subject with no prior drug in the body. A steady-state profile describes the repeating concentration pattern after enough time on a fixed regimen for concentrations to repeat from one dosing interval to the next.
The distinction matters even when the same dose and model parameters are used. A single-dose concentration is not the steady-state concentration at the same time after dosing, because steady state includes contributions from earlier doses. Similarly, total single-dose AUC and steady-state AUC over a dosing interval can be comparable under linear pharmacokinetics, but their time windows and clinical interpretations differ.
The formulas below use an intravenous bolus in a one-compartment model with linear, first-order elimination. They provide a transparent reference case for checking a simulation. More complex population PK models can be simulated using their own structural equations, but the simulation still needs the correct dosing condition and exposure window.
Single-Dose Exposure Under First-Order Elimination
Assume an intravenous dose \(D\) enters the central compartment instantly, the apparent volume of distribution \(V\) is constant, and elimination is first order with clearance \(CL\). Define the elimination rate constant \(k=CL/V\). There is no absorption phase for an intravenous bolus, and no drug is present at time zero before administration.
The initial concentration is \(D/V\). Concentration then declines exponentially. Integrating the profile from time zero to a finite time \(T\) gives the partial AUC; integrating to infinity gives total single-dose AUC.
The total AUC depends on dose and clearance, while the fraction of total AUC captured by time \(T\) depends on \(kT\). Consequently, an AUC reported over a fixed interval is not automatically the same quantity as AUC to infinity. A simulation should use the exposure window specified by the clinical question.
Worked Example: Single-Dose Concentration and Partial AUC
Consider a hypothetical 500 mg intravenous bolus in a subject with \(V=50.0\) L and \(CL=5.00\) L/h. Calculate the concentration at 12 h, AUC from 0 to 12 h, and total single-dose AUC.
First, \(k=CL/V=5.00/50.0=0.1000\ \mathrm{h^{-1}}\), and the initial concentration is \(D/V=500/50.0=10.00\ \mathrm{mg/L}\). Thus:
For the partial AUC, substitute \(D/CL=500/5.00=100.0\ \mathrm{mg\cdot h/L}\):
The total single-dose AUC is \(500/5.00=100.0\ \mathrm{mg\cdot h/L}\). The 0-to-12-hour AUC is smaller because some exposure occurs after 12 h. These results assume the stated clearance and volume remain constant and elimination is first order.
Steady-State Exposure for a Repeated Bolus Regimen
Now suppose the same dose \(D\) is administered every \(\tau\) hours, with the same linear one-compartment model. At steady state, the concentration at time \(t\) after a dose is the sum of the remaining contributions from that dose and all earlier doses. The dose schedule is fixed, and \(0\leq t<\tau\).
For this model, a steady-state profile exists because \(k>0\) and the contribution from each successively earlier dose is multiplied by \(e^{-k\tau}\), a number between zero and one. Summing these contributions gives a geometric series:
The post-dose maximum is at \(t=0\), and the pre-dose minimum is the concentration just before the next dose, at \(t=\tau\). Their formulas follow by evaluating the profile at these two points.
The steady-state AUC during one dosing interval is obtained by integrating the profile from 0 to \(\tau\). This produces an important result: under linear elimination, the interval AUC is dose divided by clearance, just as the total AUC after one dose is dose divided by clearance.
This derivation shows why steady state does not multiply the AUC within each interval by an accumulation factor: the profile is higher than after one dose, but the AUC is calculated over one interval at steady state. The total AUC over several steady-state intervals is the number of intervals multiplied by \(D/CL\).
Worked Example: Steady-State Peak, Trough, and Interval AUC
Use the hypothetical 500 mg dose and \(V=50.0\) L, \(CL=5.00\) L/h from the previous example, now administered every 12 h. Calculate the steady-state peak, trough, and AUC during one interval.
Here \(k=0.1000\ \mathrm{h^{-1}}\), \(\tau=12\) h, and \(e^{-k\tau}=e^{-1.2}=0.301194\). The post-dose maximum is:
The trough is calculated from unrounded values:
The AUC across one 12-hour steady-state interval is:
For comparison, the single-dose AUC from 0 to 12 h was 69.88 mg·h/L, not 100.0 mg·h/L. The steady-state interval includes the residual concentration from prior doses; the single-dose interval does not.
Match the Simulation to the Clinical Question
The choice between a single dose and steady state should follow the intended decision, rather than convenience or the availability of a closed-form equation. A first-dose question may concern early tolerability, an initial concentration, or exposure before repeated dosing has occurred. A maintenance-regimen question usually concerns the repeating profile after the regimen has reached steady state. An exposure target must also specify its metric and time window: for example, total AUC per dose interval, peak concentration, trough concentration, or time within a concentration range.
The following comparison helps keep the scenarios distinct:
| Simulation condition | What it represents | Typical exposure calculation |
|---|---|---|
| One dose, no prior drug | Response to a single administration | AUC over a specified finite window or to infinity |
| Repeated regimen at steady state | Repeating profile under the maintenance schedule | AUC over one interval, peak, trough, or a time-based metric |
| First interval of a regimen | Early treatment before steady state | Exposure over the stated early interval, accounting for doses actually given |
In population simulation, the scenario should be applied consistently to each virtual subject. If individual parameters differ, the same dose schedule can produce different times to approach a repeating profile and different exposure metrics. A steady-state calculation is appropriate only when the clinical question concerns that condition and the model supports a stable repeating profile. It should not be substituted for first-dose exposure merely because the steady-state formula is convenient.
Worked Example: Same Daily Dose, Different Steady-State Profiles
Suppose a hypothetical linear-PK medicine is administered either as 500 mg every 12 h or 1000 mg every 24 h. Let \(V=50.0\) L and \(CL=5.00\) L/h, so \(k=0.1000\ \mathrm{h^{-1}}\). Compare steady-state AUC per day and the peak and trough for each regimen. Assume the doses are instantaneous intravenous boluses and the stated parameters remain constant.
For 500 mg every 12 h, the interval AUC is \(500/5.00=100.0\ \mathrm{mg\cdot h/L}\). There are two intervals per day, so the 24-hour steady-state AUC is \(2(100.0)=200.0\ \mathrm{mg\cdot h/L}\). From the previous calculation, its peak and trough are 14.31 mg/L and 4.310 mg/L.
For 1000 mg every 24 h, \(D/V=1000/50.0=20.00\ \mathrm{mg/L}\), and \(e^{-k\tau}=e^{-2.4}=0.09071795\). The peak and trough are:
The 24-hour interval AUC is \(1000/5.00=200.0\ \mathrm{mg\cdot h/L}\). Thus the two regimens have the same daily AUC under the linear model, but different peak and trough concentrations. If the clinical decision depends on peak or trough, equal daily AUC is not enough to treat the schedules as equivalent.
Diagnostics, Alternatives, and Limitations
Analytic formulas are useful checks, not universal replacements for model-based simulation. For the one-compartment bolus model, verify that concentrations decline within an interval, that \(C_{\mathrm{ss,max}}\) exceeds \(C_{\mathrm{ss,min}}\), and that the steady-state interval AUC equals \(D/CL\). If calculated concentrations increase during the interval or a reported trough exceeds the peak under these assumptions, check the time origin, units, and formula implementation.
A frequent error is to use a single-dose profile for a maintenance-regimen decision, or to interpret the first 12 hours after one dose as the steady-state 12-hour interval. The correction is to identify whether the exposure question concerns one dose, an early treatment interval, or the repeating profile, then use the corresponding simulation condition and observation window. Another error is to assume that equal AUC implies equal concentration profiles. The example above shows why that is false: peak and trough depend on dose size and dosing interval even when the total daily dose is the same.
For a linear model with more complex absorption or distribution, exposure can still be obtained by integrating the model-predicted concentration profile, but the simple bolus equations for peak and trough may not apply. A direct numerical simulation is often preferable when the structural model is complex. For nonlinear PK, dose proportionality and superposition may fail; the relations \(D/CL\) and the geometric accumulation expression cannot be assumed to hold without checking the model. Time-varying clearance, changing covariates, or a regimen that is stopped or altered also do not produce the fixed repeating profile assumed by the steady-state formulas.
A useful alternative is to simulate the model directly under the intended dosing condition and numerically integrate concentration over the prespecified window. For the simple linear bolus case, compare that output with the analytic results as a validation check. Disagreement can reveal inconsistent units, a mistaken dosing interval, an incorrect definition of the AUC window, or a simulation that has not reached the intended steady-state condition. The formulas do not determine which exposure metric is clinically relevant; that choice must come from the clinical target and decision context.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions below.
- For a single 300 mg intravenous bolus with \(CL=3.00\) L/h, what is the total AUC to infinity under linear PK?
- With the same dose and clearance, what is the steady-state AUC over one dosing interval if the dose is given every 8 h?
- Why is the single-dose AUC from 0 to 8 h generally not equal to the steady-state AUC over an 8-hour interval?
- Two regimens have the same daily dose and linear PK. Can their steady-state peaks and troughs differ? Explain.
Solutions. (1) \(\mathrm{AUC}_{0-\infty}=D/CL=300/3.00=100.0\ \mathrm{mg\cdot h/L}\). (2) The steady-state interval AUC is also \(D/CL=100.0\ \mathrm{mg\cdot h/L}\); the 8-hour interval determines the profile shape but not this AUC in the stated linear model. (3) The single-dose interval has no contributions from earlier doses, whereas the steady-state interval includes residual drug; therefore the profiles integrated over those windows differ. (4) Yes. Different dose sizes and intervals can yield the same daily AUC but different peak and trough concentrations, as the worked comparison demonstrates.